Identification of an Exosome-Related Signature for Predicting Prognosis, Immunotherapy Efficacy, and Tumor Microenvironment in Lung Adenocarcinoma

<div>Construction and evaluation of the novel nomogram. (a) The nomogram for predicting the survival probability of LUAD patients. The calibration plots of the nomogram for predicting OS probability for 1, 3, and 5 years in the TCGA-LUAD cohort (B), GSE68465 cohort (c), and GSE72094 cohort (d).</div>

Journal of Oncology

fig5

Figure 5

Figure 5: Identification of an Exosome-Related Signature for Predicting Prognosis, Immunotherapy Efficacy, and Tumor Microenvironment in Lung Adenocarcinoma 

Figure 5 | Identification of an Exosome-Related Signature for Predicting Prognosis, Immunotherapy Efficacy, and Tumor Microenvironment in Lung Adenocarcinoma 